Plasma glutamine status at intensive care unit admission: an independent risk factor for mortality in critical illness
Open Access
- 7 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-9
- https://doi.org/10.1186/s13054-021-03640-3
Abstract
A plasma glutamine concentration outside the normal range at Intensive Care Unit (ICU) admission has been reported to be associated with an increased mortality rate. Whereas hypoglutaminemia has been frequently reported, the number of patients with hyperglutaminemia has so far been quite few. Therefore, the association between hyperglutaminemia and mortality outcomes was studied in a prospective, observational study. Consecutive admissions to a mixed general ICU were eligible. Exclusion criteria were < 18 years of age, readmissions, no informed consent, or a ‘do not resuscitate’ order at admission. A blood sample was saved within one hour from admission to be analysed by high-pressure liquid chromatography for glutamine concentration. Conventional risk scoring (Simplified Acute Physiology Score and Sequential Organ Failure Assessment) at admission, and mortality outcomes were recorded for all included patients. Out of 269 included patients, 26 were hyperglutaminemic (≥ 930 µmol/L) at admission. The six-month mortality rate for this subgroup was 46%, compared to 18% for patients with a plasma glutamine concentration < 930 µmol/L (P = 0.002). A regression analysis showed that hyperglutaminemia was an independent mortality predictor that added prediction value to conventional admission risk scoring and age. Hyperglutaminemia in critical illness at ICU admission was an independent mortality predictor, often but not always, associated with an acute liver condition. The mechanism behind a plasma glutamine concentration outside normal range, as well as the prognostic value of repeated measurements of plasma glutamine during ICU stay, remains to be investigated.Keywords
Funding Information
- Stockholms Läns Landsting
- Svenska Sällskapet för Medicinsk Forskning
- Karolinska Institute
This publication has 29 references indexed in Scilit:
- Glutamine in the pathogenesis of acute hepatic encephalopathyNeurochemistry International, 2012
- Glutamine and glutathione at ICU admission in relation to outcomeClinical Science, 2012
- Muscle glutamine depletion in the intensive care unitThe International Journal of Biochemistry & Cell Biology, 2005
- Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathyJournal of Hepatology, 2004
- Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSSJournal of Hepatology, 2002
- Glutamine Transport and Human Hepatocellular TransformationJournal of Parenteral and Enteral Nutrition, 1999
- Effect of a short-term infusion of glutamine on muscle protein metabolism postoperativelyClinical Nutrition, 1996
- The concentrations of free amino acids in human liver tissue obtained during laparoscopic surgeryClinical Physiology and Functional Imaging, 1996
- Intestinal Amino Acid Content in Critically III PatientsJournal of Parenteral and Enteral Nutrition, 1995
- Metabolic disorders in severe abdominal sepsis: Glutamine deficiency in skeletal muscleClinical Nutrition, 1982